Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm
Public ClinicalTrials.gov record NCT01236768. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Randomized, Phase 3 Study of the Contraceptive Efficacy and Safety of Agile Transdermal Contraceptive Delivery System in Comparison to an Oral Contraceptive (OC) Containing 150 mcg LNG and 30 mcg EE
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the efficacy and safety of a low dose transdermal contraceptive delivery system containing ethinyl estradiol and levonorgestrel.
Study identification
- NCT ID
- NCT01236768
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 407 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2010
- Primary completion
- May 31, 2011
- Completion
- May 31, 2011
- Last update posted
- Sep 14, 2017
2010 – 2011
United States locations
- U.S. sites
- 21
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Green Valley | Arizona | 85614 | — |
| Not listed | Tucson | Arizona | 85712 | — |
| Not listed | Los Angeles | California | 90036 | — |
| Not listed | Los Angeles | California | 90057 | — |
| Not listed | West Hills | California | 91307 | — |
| Not listed | Boynton Beach | Florida | 33472 | — |
| Not listed | South Miami | Florida | 33143 | — |
| Not listed | St. Petersburg | Florida | 33709 | — |
| Not listed | Newburgh | Indiana | 47630 | — |
| Not listed | Louisville | Kentucky | 40291 | — |
| Not listed | Las Vegas | Nevada | 89109 | — |
| Not listed | Las Vegas | Nevada | 89128 | — |
| Not listed | Kernersville | North Carolina | 27284 | — |
| Not listed | Englewood | Ohio | 45322 | — |
| Not listed | Tulsa | Oklahoma | 74105 | — |
| Not listed | Mt. Pleasant | South Carolina | 29464 | — |
| Not listed | Corpus Christi | Texas | 78414 | — |
| Not listed | Sugar Land | Texas | 77479 | — |
| Not listed | Newport News | Virginia | 23606 | — |
| Not listed | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01236768, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2017 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01236768 live on ClinicalTrials.gov.